News

The Lily Foundation celebrates approval of first ever mitochondrial disease treatment by NICE

14 August 2025 | Leber’s hereditary optic neuropathy, idebenone, Pharmacology, new therapies, research

The Lily Foundation, the UK’s leading mitochondrial disease charity, is today celebrating a landmark achievement in the fight against the disease – the first ever treatment for a mitochondrial condition has been approved for use on the NHS in England....